β¨ Medicine Distribution Consent
NEW ZEALAND GAZETTE, No. 71 β 2 JULY 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Levetiracetam Actavis
Levetiracetam 250mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Levetiracetam Actavis
Levetiracetam 500mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Levetiracetam Actavis
Levetiracetam 750mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Levetiracetam Actavis
Levetiracetam 1000mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Ranitidine Relief
Ranitidine hydrochloride 167.5mg equivalent to Ranitidine 150mg
Film coated tablet
Mylan New Zealand Limited
Adcock Ingram Limited β A Medreich Group Company, Bangalore, India
Medreich Limited, Bangalore, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Sylvant
Siltuximab 100mg
Powder for infusion concentrate
Janssen-Cilag (New Zealand) Limited
Cilag AG, Schaffhausen, Switzerland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Sylvant
Siltuximab 400mg
Powder for infusion concentrate
Janssen-Cilag (New Zealand) Limited
Cilag AG, Schaffhausen, Switzerland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Voltaren Osteo Gel 12 Hourly
Diclofenac diethylamine 2.32% equivalent to diclofenac 2%
Topical gel
Novartis Consumer Health Australasia Pty Limited (New Zealand)
Novartis Consumer Health SA, Nyon, Switzerland
Dated this 26th day of June 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go3848
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
43
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare26 June 2015
Medicines, Consent, Distribution, Levetiracetam, Ranitidine, Sylvant, Voltaren
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social WelfareMedicines, Consent, Distribution
NZ Gazette 2015, No 71